EvolutionaryScale vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 55)
EvolutionaryScale logo

EvolutionaryScale

ChallengerHealthcare & Life Sciences

AI Protein Design & Biology

AI biology lab building protein design models (ESM3, 98B params). Founded 2023 by ex-Meta scientists. $142M seed. Acquired by Chan Zuckerberg Biohub Nov 2025.

AI VisibilityBeta
Overall Score
C55
Category Rank
#170 of 596
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
53
Perplexity
61
Gemini
57

About

EvolutionaryScale was an AI research lab founded in 2023 by former Meta AI protein team scientists, including CEO Alexander Rives. Based in New York City, the company developed frontier AI models for protein design and biological discovery. Its flagship model ESM3 is a 98-billion-parameter generative AI system trained on 2.78 billion protein sequences capable of reasoning over protein sequence, structure, and function simultaneously.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

55
Overall Score
88
#170
Category Rank
#3
72
AI Consensus
78
stable
Trend
stable
53
ChatGPT
83
61
Perplexity
87
57
Gemini
85
49
Claude
90
57
Grok
92

Key Details

Category
AI Protein Design & Biology
AI Drug Discovery
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only EvolutionaryScale
AI Protein Design & Biology
Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.